Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Inhye Ahn, M.D.

Concepts (141)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Inhye Ahn's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Inhye Ahn has written about over time.
Philadelphia Chromosome, 1 publications between 2013 and 2013, average publication date September 2013. Pneumocystis carinii, 1 publications between 2016 and 2016, average publication date August 2016. Pneumonia, Pneumocystis, 1 publications between 2016 and 2016, average publication date August 2016. Irritable Bowel Syndrome, 1 publications between 2017 and 2017, average publication date December 2017. Safety, 1 publications between 2017 and 2017, average publication date December 2017. Pyrazoles, 12 publications between 2016 and 2021, average publication date August 2018. Pyrimidines, 13 publications between 2016 and 2023, average publication date December 2018. Adenine, 18 publications between 2016 and 2024, average publication date September 2019. Piperidines, 18 publications between 2016 and 2024, average publication date September 2019. Drug Resistance, Neoplasm, 6 publications between 2017 and 2024, average publication date April 2020. Antineoplastic Agents, 12 publications between 2014 and 2024, average publication date May 2020. Leukemia, Lymphocytic, Chronic, B-Cell, 35 publications between 2016 and 2024, average publication date October 2020. Protein Kinase Inhibitors, 14 publications between 2018 and 2023, average publication date November 2020. Antineoplastic Combined Chemotherapy Protocols, 7 publications between 2013 and 2023, average publication date February 2021. Antibodies, Bispecific, 3 publications between 2018 and 2023, average publication date April 2021. Tumor Suppressor Protein p53, 3 publications between 2020 and 2021, average publication date April 2021. Lymphoma, B-Cell, 2 publications between 2020 and 2022, average publication date October 2021. Vidarabine, 2 publications between 2020 and 2024, average publication date June 2022.

To see the data from this visualization as text, click here.
Ahn's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.